SEC Tracker
Get the app

Alaunos Therapeutics TCRT

Robert W Postma filed 13D/A on Oct 15, 2026

Ownership stake disclosure by Robert W Postma (amended)

Form
Schedule 13D/A
Filed
Importance
Notable
  1. Robert W Postma filed 13D/A on Oct 15, 2026.
  2. Issuer has 3,440,670 shares outstanding as of Oct 13, 2026.
  3. Repurchase agreement involves $1.6 million for preferred stock.
  4. Lock-up agreements for 180 days on stock sales.

Written from the Schedule 13D/A on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Alaunos Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. BioCardia BCDA public float $10M, Jun 30, 2025
  2. Raphael Pharmaceutical RAPH public float $9M, Jun 30, 2025
  3. Traws Pharma ONTX public float $10M, Jun 30, 2025
  4. Mannatech MTEX public float $10M, Jun 30, 2025
  5. Bioxytran BIXT public float $9M, Jun 30, 2025